The percentages of CD3-CD56+CD16+ NK cells in asthma with AURVIs group decreased to 13.20 (4.62 ~ 21.23) % on day 8 (p < 0.001) and 9.35 (4.32 ~ 18.76) % on day 14 (p < 0.001), respectively, but the numbers were still higher than those at baseline. Here, NCAM1 is linked to asthma.